Humana Reports Third Quarter 2021 Financial Results; Revises Full Year 2021 EPS Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Humana (HUM) PT Lowered to $480 at Cantor Fitzgerald
November 3, 2021 11:11 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Humana (NYSE: HUM) to $480.00 (from $508.00) while maintaining an Overweight rating.
The analyst commented, ". We reiterate our Overweight rating on HUM shares but reduce our price target to $480 from $508. This morning, November 3, the company reported 3Q21 results which on... More
Humana (HUM) Tops Q3 EPS by 17c, Updates FY Guidance
November 3, 2021 6:35 AM EDTHumana (NYSE: HUM) reported Q3 EPS of $4.83, $0.17 better than the analyst estimate of $4.66. Revenue for the quarter came in at $20.7 billion versus the consensus estimate of $20.91 billion.
GUIDANCE:
Humana sees Q4 2021 EPS of $20.50, versus the consensus of... More
